| Autor: |
Johnson, Judith A., Lister, Sarah A., Porter, Donna V., Smith, Pamela W., Thaul, Susan, Williams, Erin D. |
| Předmět: |
|
| Zdroj: |
Congressional Research Service: Report; 8/25/2008, p1-CRS-7, 10p, 1 Chart |
| Abstrakt: |
The Administration's FY2009 budget request of $2.676 billion for the Food and Drug Administration (FDA) would provide a 17.9% increase ($406 million) over FY2008. User fees would make up 23.5% of the total amount requested and would account for 19.8% of the proposed increase. These figures reflect the Administration's amended request, issued in June 2008, which added $275 million to the amount originally requested by the Administration in February 2008. Based on the initial request, cost-of-living pay increases, rather than new program activities, would have accounted for about half of the total increase over FY2008. With the amended request, such pay increases would use only 7.7%. The amended FY2009 request, according to budget documents, would provide for expanded activities to ensure the safety of foods and drugs, enhance workforce development and recruitment, and accelerate the availability of new medical products. The user fee request includes $609 million in currently authorized fees and $21 million for generic human and animal drug review. The budget justification documents include an additional $27 million in proposed fees for reinspections and food and animal feed certification. The Senate Committee on Appropriations, in S. 3289, recommended an FY2009 total of $2.646 billion for FDA. It did not include the generic drug user fees, the proposed reinspection and certification fees, or the authorized fees for the advisory review of direct-to-consumer television prescription drug advertising. Updates to this report will track legislative activity as the House Committee on Appropriations and the full Senate and House consider FY2009 appropriations. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
